Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

K42 and K124 keratins are only found in horse hoof lamellae.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Some drugs can cause permanent hair loss, though it's rare.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Sheep with chronic Sarcoptes scabiei dermatitis have altered keratin expression in their skin.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Immature hair cells can grow and change into different types of hair cells over time.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Minoxidil boosts hair growth by increasing cell production and survival.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Human hair is made up of different keratins, some strong and some weak, with specific types appearing at various stages of hair growth.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Trichohyalin may trigger the immune response causing alopecia areata.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Melanocytes in the outer root sheath are likely stem cells that grow fast but stay immature.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Targeting CXCL12 may help treat hair loss caused by androgens.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.